What is this study about?
The IMPACT trial is an international study looking at how well PSA (prostate-specific antigen) screening for prostate cancer works for people with inherited mutations. This report shared early results of screening in people with Lynch syndrome.
Initial results from the IMPACT trial show that PSA testing to screen for prostate cancer in people with Lynch syndrome can detect aggressive early prostate cancers. These findings support the use of PSA screening in men with Lynch syndrome, particularly men with an inherited mutation in an MSH2 or MSH6 gene.